Jun 17, 2019

Emerging countries issue a flood of new bonds

Ukrainian President Volodymyr Zelensky. Photo: Emmanuel Dunand/AFP/Getty Images

Ukraine sold 1 billion euros of 7-year bonds in its first offer to international markets under new president — and former comedian — Volodymyr Zelensky, who was elected in April.

Why it matters: Ukraine's latest offering comes amid a flurry of new bond issuance, particularly from emerging markets, as declining interest rates in the U.S. and Europe (where German government bond yields have hit all-time lows) are encouraging countries to load up on new debt.

  • Last week Indonesia, Croatia, Lithuania, Ukraine, Peru and Serbia all announced plans to issue new bonds, with the first 4 successfully completing debt sales. Ecuador is said to be in talks to issue new bonds as well.

By the numbers: Ukraine's bonds came with a coupon on 6.75%, a far cry from the 10.5% yield on 7-year issues in January.

  • The bond issue could not have come at a better time. Ukrainian bond yields spiked last year as emerging-market debt sold off broadly, and as Zelensky rose in polls, because of uncertainty about his economic strategy and ability to deal with Russia.

The big picture: Emerging market countries and corporate entities have already issued a record amount of debt and look poised to increase the total further this year. Higher debt will put increased stress on balance sheets in the event of a global economic downturn.

Go deeper: Emerging markets are hot again after a rocky 2018

Go deeper

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

Go deeperArrow10 mins ago - Health

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.

Go deeperArrow24 mins ago - Health

The Fed rescues Wall Street, but Main Street is another story

llustration: Aïda Amer/Axios

In less than a month, the Federal Reserve has unleashed a multi-trillion dollar tour de force to buoy the U.S. economy against the COVID-19 pandemic.

Why it matters: While it has steadied the markets, the Fed is poorly equipped to offset the hit being absorbed by small business owners and the close to 17 million Americans who have filed for unemployment in just the past three weeks.